ArticleUpdates in surgery2026
Radiofrequency-based stump management and ductal ablation in robotic central pancreatectomy: a technical note and initial experience.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central pancreatectomy is a parenchyma-sparing procedure for benign or borderline lesions of the pancreatic neck and proximal body but remains associated with high rates of postoperative pancreatic fistula (POPF), largely related to distal remnant management and pancreatico-enteric reconstruction. We describe a novel robotic-assisted technique incorporating radiofrequency (RF)-based stump management combined with endoductal ablation of the main pancreatic duct as a reconstruction-free strategy. This approach is based on our previous preclinical and clinical experience demonstrating that RF-assisted pancreatic transection may improve stump sealing, while ductal ablation induces controlled exocrine atrophy, reducing enzymatic output and potentially mitigating POPF. The technique includes intraoperative ultrasound-guided resection, selective RF application at the transection surface, and intraductal RF ablation using a catheter-based system, without distal pancreatico-enteric anastomosis. Four consecutive patients underwent the procedure. No patient developed POPF or other pancreas-specific complications. This RF-based hybrid strategy represents a biologically driven alternative to conventional reconstruction in central pancreatectomy, with the potential to reduce morbidity while preserving pancreatic parenchyma. These preliminary findings should be regarded as a proof of technical feasibility rather than as evidence of clinical efficacy in reducing POPF, and require validation in larger prospective studies.
Identifiers
42771330What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.